TrialThe European respiratory journal2025

Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency.

J Michael Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.